ArticleRadiology case reports2026
Congenital Absence of the Inferior Vena Cava With Azygos Continuation.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interruption of the inferior vena cava (IVC) with azygos continuation is a rare congenital anomaly resulting from abnormal embryologic development of the venous system. Although frequently associated with polysplenia and other visceral or cardiovascular malformations, many cases remain asymptomatic. Recognition of this variant is important, as it may mimic pathological masses on imaging and complicate procedures requiring central venous access. An 80-year-old woman presented with progressive functional decline following a fall. Her medical history included multiple chronic comorbidities. A contrast-enhanced thoracoabdominal computed tomography scan performed during her diagnostic workup revealed an interruption of the IVC at the infrarenal segment, with venous drainage diverted through a markedly dilated azygos vein. Additional findings included polysplenia and necrotic retroperitoneal lymphadenopathy, unrelated to the vascular anomaly. The interrupted IVC represented an incidental, asymptomatic finding. The patient's clinical management focused on evaluation of the lymphadenopathy and her comorbidities, with no intervention required for the vascular variant. Interruption of the IVC with azygos continuation occurs in less than 0.3% of the population and may be misinterpreted as lymphadenopathy or mediastinal masses. This variant has implications for procedures including transfemoral cardiac catheterization, IVC filter placement, venography, and cardiopulmonary bypass, as femoral access may be ineffective. Awareness of this anomaly also helps differentiate it from acquired causes of azygos dilation due to venous obstruction. Although rare, congenital interruption of the IVC with azygos continuation is clinically significant. Accurate identification is essential to avoid misdiagnosis and to ensure safe planning for interventions requiring venous access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.